Both major corporate entities bearing the Verve name—Verve Therapeutics in biotechnology and Verve Group SE in digital advertising—are entirely legitimate, verified enterprises operating within the strict bounds of international corporate law, financial transparency, and public market regulations. Verve Therapeutics operates as a clinical-stage gene-editing firm backed by major pharmaceutical acquisitions, while Verve Group SE is publicly traded on recognized public stock exchanges such as Nasdaq Stockholm and the Frankfurt Stock Exchange. Both organizations maintain transparent governance, verifiable physical headquarters, and professional executive teams, ensuring complete institutional and commercial legitimacy.